Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aquleaf
    Member
    • Mar 2010
    • 38

    #1

    Questions regarding ChIP sonication and ChIP-Seq on heterochromatin

    Hi all. I have a problem regarding ChIP sonication. We are culturing one type of cells in two different states. One state shows active transcription (say State A), while the other one shows decreased overall transcription activity (say State B). We found that State B cells were very difficult to be sheared by sonication. The common solutions in this situation are to increase sonication power and extend the sonication treatment. However, we suspect that even though enhanced sonication might generate more small fragments, these fragments might be from chromatin with destroyed protein-DNA structure. The amount of ChIPed DNA might not increase much or even decrease. Thus, it seems that increasing the cell amount might be a good choice. But, the problem is we want to compare the binding profile differences between two states. Is that OK if we use different cell amounts in ChIP of two states of cells?

    One more question. Is there anyway to perform ChIP-Seq on heterochromatin marks?

    Thanks a bunch! Any help will be greatly appreciated.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Working...